Librax (Chlordiazepoxide, Clidinium Bromide)

Chlordiazepoxide enhances the activity of the neurotransmitter GABA at the GABA‑A receptor, increasing neuronal inhibition. This results in reduced anxiety, sedation, and muscle relaxation, which together help alleviate the emotional component of gastrointestinal distress.

The specific dose of Librax is determined by the prescribing clinician based on the individual’s medical condition, age, and response to therapy. Dosage adjustments are made according to therapeutic goals and tolerability, and patients should follow the prescriber’s instructions exactly.

Safety of Librax in pregnancy or while nursing has not been fully established. Healthcare providers usually weigh potential benefits against possible risks before prescribing it to pregnant or lactating women, and alternative treatments may be considered when appropriate.

To order Librax, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Unlike single‑agent therapies, Librax combines a benzodiazepine with an anticholinergic, addressing both anxiety and gut spasm simultaneously. Other IBS treatments may target only one aspect, such as antispasmodics alone or antidepressants for pain, making Librax a unique option for patients with prominent anxiety‑related symptoms.

Librax tablets should be stored at ambient temperature, preferably below 25 °C. Keep them in the original packaging to protect from moisture and light, and store them out of reach of children.

Librax is taken orally, usually with a glass of water. The tablet should be swallowed whole and not chewed or crushed, unless a healthcare professional advises otherwise. Dosing times are set by the prescriber to match the patient’s symptom pattern.

The most serious risks include severe respiratory depression, especially when combined with other CNS depressants, profound hypotension, paradoxical anxiety or agitation, and rare but serious allergic reactions such as anaphylaxis. Patients should seek immediate medical attention if they experience any of these symptoms.

Librax is contraindicated in individuals with known hypersensitivity to chlordiazepoxide, clidinium bromide, or any component of the formulation. It should also be avoided in patients with acute narrow‑angle glaucoma, severe urinary retention, or those taking potent CNS depressants without close medical supervision.